Biora Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Biora Therapeutics

15/05/2024 22:37

* Biora Therapeutics Inc  BIOR.OQ  reported a quarterly
adjusted
loss of 14 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of $-1.59.  The lone analyst forecast for the
quarter was for a loss of 45 cents per share. 
    * Revenue rose 27,000% to $542.00 thousand from a year ago;
analysts expected zero. 
    * Biora Therapeutics Inc's reported EPS for the quarter was
a loss
of 14 cents​.
    * The company reported a quarterly loss of $4.19 million.
    * Biora Therapeutics Inc shares had fallen by 32.9% this
quarter and lost 45.3% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Biora
Therapeutics Inc is $10.30 
This summary was machine generated from LSEG data May 15 at
09:37 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.45          -0.14          Beat
 Dec. 31 2023      -0.59          -0.62          Missed
 Sep. 30 2023      -0.92          -4.89          Missed
 Jun. 30 2023      -1.60          -1.47          Beat